Piper Sandler & Co’s AtriCure ATRC Stock Holding History

Piper Sandler & Co’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-14,000	Closed	-$307K	–	35
2015 Q3	$307K	Buy	+14,000	New	+$350K	0.33%	41
2015 Q2	–	Sell	-21,000	Closed	-$430K	–	101
2015 Q1	$430K	Buy	21,000 +4,600	+28%	+$89.1K	0.18%	53
2014 Q4	$327K	Buy	+16,400	New	+$281K	0.16%	50

Other funds holding ATRC

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piper Sandler & Co's ATRC Position: Q4 2015 in Review

Piper Sandler & Co sold out of AtriCure (ATRC) in Q4 2015, closing a stake of 14,000 shares — an estimated $307K sold.

Piper Sandler & Co first reported a position in ATRC in Q4 2014 and held it in 3 quarters. The position peaked at $430K in Q1 2015. 118 funds tracked by Wall St. Rank hold ATRC as of Q4 2015.

Piper Sandler & Co reported no remaining AtriCure position as of Q4 2015 after selling out during the quarter.
Piper Sandler & Co sold 14,000 AtriCure shares in Q4 2015, an estimated $307K.
Piper Sandler & Co first reported a position in AtriCure in Q4 2014 and held it in 3 quarters.
Piper Sandler & Co's AtriCure position peaked at $430K in Q1 2015.
118 funds tracked by Wall St. Rank held AtriCure as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.